Strategic vs financial buyers: same teaser, different IOI
TJ Moruzzi
Published At Mon Aug 31 2026
The same business sent to a strategic buyer and a PE firm gets two very different IOIs. Same revenue, same EBITDA, same growth rate. Strategic comes in 20-30% above PE. Or strategic comes in below PE because their committee discounted the synergy. Either outcome is common.
Understanding why explains a lot about how to run a sell side process. The buyer types use different math, different time horizons, and different decision processes. Predicting which type pays the most for a given asset is one of the bankers's core jobs.
This post covers how each evaluates, the strategic premium math, the PE multiples math, when the strategic premium survives, and what it means for process design.
How strategics and PE evaluate differently
A PE firm is buying cash flow. The math is straightforward: TTM EBITDA times a multiple band, financed with debt and equity, exited in 4-6 years. The buyer is purely financial.
A strategic is buying a business that fits their existing portfolio. The math includes synergies (cost reductions, cross-sell, geographic expansion). The buyer evaluates fit, not just cash flow.
Both run their numbers. The numbers are different.
PE has a concrete IRR target (usually 20-25% on cash, 25-30% on equity) and works backward to a multiple. Strategics have a return-on-investment target on the synergy thesis and work forward from a synergy assumption.
When a strategic's synergy thesis is concrete and credible, they pay more. When the synergy thesis is vague and the committee discounts it, they pay less than PE.
Strategic premium math
The premium math: synergy value × discount rate adjustment.
Synergy value comes in three forms:
- Cost synergies. Headcount overlap, redundant systems, real estate consolidation. These are concrete and can be modeled. A strategic acquiring a competitor in the same geography typically captures 5-15% of combined operating cost.
- Revenue synergies. Cross-sell into the strategic's customer base, upsell from the strategic's products. These are softer and committees discount heavily. Typical assumption: 10-30% of stated synergy materializes.
- Multiple expansion. The acquired business gets revalued at the strategic's higher multiple post-acquisition. This is meaningful when the acquirer is publicly traded at a premium multiple.
The strategic computes its bid as: standalone PE value (TTM × multiple) plus capitalized synergies (synergy run rate × strategic multiple) minus integration cost.
Practical example: a $40M LMM business at 8x EBITDA = $40M × 1 / 8x ÷ wait let me redo. $40M business value at 8x means EBITDA of $5M. Cost synergies of $1M would add (capitalized at 8x) another $8M. Revenue synergies of $0.5M run rate at 30% credit add another $1.2M. Strategic IOI: $50M.
Same business at PE math: $5M × 8x = $40M. Strategic premium: $10M, or 25%.
When this premium shows up at IOI, sellers benefit. When the strategic's committee discounts the synergy thesis to zero, the strategic comes in at PE pricing.
PE multiples math
PE math is more constrained. The mid-market PE buyer:
- Targets 25%+ unlevered IRR
- Uses leverage of 4-6x EBITDA
- Holds 4-6 years
- Exits at the same or higher multiple
That gives them a multiple range based on EBITDA growth assumptions, debt cost, and exit multiple expectation. For a typical LMM deal in 2026: 6-9x EBITDA depending on quality.
Quality factors that move within the band:
- Recurring revenue mix (90%+ recurring → 8-9x; 30% recurring → 6-7x)
- Customer concentration (less concentrated → higher)
- Margin profile (gross margin 60%+ vs 35%)
- Growth rate (organic growth 15%+ vs 5%)
- Industry dynamics (consolidation theme → higher)
PE multiples don't have a strategic premium component. They're capped by the IRR math. A PE firm that pays 12x for an 8x asset will hit weak IRR even if they execute well.
Why same teaser, different IOI
Same business, two different bidders. The IOI looks different because:
- PE bid: $40M, financing structure listed, 60-day exclusivity
- Strategic bid: $48M, "subject to synergy validation in diligence," pre-conditions on integration plan
The dollar number isn't directly comparable. PE is a clean offer at a multiple. Strategic is a synergy-loaded offer with diligence conditions.
The banker's job at this stage is to read the conditions. A strategic bid at $48M with three diligence outs is worth less than a PE bid at $40M with clean conditions. Sellers who only look at the headline number miss this.
When the strategic premium survives diligence
Strategic premiums survive diligence when:
- The synergy thesis is concrete (not "we'll figure out cross-sell")
- Cost synergies are quantified (specific overlapping departments, specific real estate)
- The strategic has a track record of executing acquisitions in this space
- Committee approval is upstream of the IOI, not downstream
When any of these are missing, the premium tends to evaporate. By LOI, the strategic has revised down to PE-style pricing.
Bankers learn to read the strategic's track record. A strategic that has closed 5+ acquisitions in the past 4 years and integrated them on time is credible. A strategic in their first acquisition is high-variance.
When the strategic premium doesn't show up
The strategic premium doesn't survive when the strategic's committee:
- Discounts the revenue synergy by 70%+
- Adds an integration risk premium
- Caps the multiple based on internal "comparable transactions"
Combined, these can bring the strategic bid below PE. In that case, PE wins the deal even if the strategic showed initial interest.
This is why dual-track is the default. Running PE and strategic in parallel keeps both honest. If the strategic premium materializes, the seller gets it. If it doesn't, the PE process is still live.
Process implications
Three implications for sell side:
Implication 1: Dual track is the default. Running PE only forecloses the upside. Running strategic only forecloses the floor.
Implication 2: The CIM should support both buyers. Synergy hooks for strategics (overlap with their customer base, sector dynamics, expansion thesis) and clean cash flow framing for PE (recurring revenue, margin trajectory, growth durability). The CIM tries to do both without dilution.
Implication 3: Sequenced rounds favor strategics. A first round of PE-only IOIs followed by a second round inviting strategics to match the leading bid can pressure strategics to bid above their initial assumption. This works when there's genuine strategic interest and PE established a strong floor.
Bottom line
PE and strategic evaluate the same business with different math. PE is constrained by IRR. Strategics are constrained (and freed) by their synergy thesis. The strategic premium is real but doesn't always survive committee.
The right process runs both in parallel. The CIM supports both narratives. The banker's judgment on which bid actually closes is informed by the conditions and the buyer's track record, not just the headline number.
Sellers who insist on "strategic only" or "no PE" usually get worse outcomes than sellers who let the market decide.
FAQ
Is the strategic premium real? Yes, but inconsistent. It survives when the synergy thesis is concrete, cost synergies are quantified, and the strategic has a track record. It evaporates when committees discount synergies in diligence.
Should I always run dual track? For most LMM deals, yes. The exception is when the seller has strong existing strategic relationships that genuinely preempt the PE conversation, or the business has no real PE-fit.
What's a typical strategic premium? 10-25% above PE pricing when it materializes. Cost-synergy-heavy strategics in adjacent geographies can pay 30%+. Pure cross-sell strategic premiums are smaller and less reliable.
When does PE pay more than strategic? When the strategic's committee discounts the synergy story aggressively, or when the PE firm has a thesis that this asset accelerates a portfolio company's growth (platform play). PE platform plays sometimes pay strategic-level premiums.
What's a synergy multiple? The multiple applied to capitalized synergy run rate when computing strategic value. Strategic acquirers often apply their own trading multiple (which may be higher than the LMM standalone multiple), creating multiple expansion as part of the bid.
How do I tell if a strategic's synergy thesis will hold? Track record matters. A strategic that has closed multiple acquisitions in the past 4 years and integrated them on time is credible. Watch for committee status: who has authority, who has reviewed the thesis, what stage of approval the bid is at.
Why do strategics often submit conditional bids? Their committee approval is partial at IOI. The bid is conditional on completing synergy validation in diligence. PE bids are usually less conditional because they don't have committee dependency.
What's a dual-track process? Running strategic and PE buyers in parallel through the same auction. The seller gets the best of both worlds: strategic premium upside, PE-driven competitive tension.
